William H. Matthai, MD

Low Incidence of Bleeding Using the FemoStop® in Conjunction with Aggressive Quality Improvement Management

06/19/2008

Presently, in many laboratories, the anticoagulant of choice in PCI is unfractionated heparin (UFH). Heparin inhibits reactions that lead to the clotting of blood in the coagulation cascade. In combination with antithrombin III (heparin...

Presently, in many laboratories,...

06/19/2008

Cath Lab Digest

Feature

Low Incidence of Bleeding Using the FemoStop® in Conjunction with Aggressive Quality Improvement Management

06/19/2008

Fern M. Kaufman , BSN, RN;

Dennis Coloski , BS, RN;

William H. Matthai , MD;

Presently, in many laboratories,...

06/19/2008

Cath Lab Digest

Original Contribution

Patient Satisfaction is Comparable to Early Discharge versus Overnight Observation after Elective PCI (see full title below)

09/01/2009

John W. Hirshfeld Jr.;

William H. Matthai , MD;

Howard C. Herrmann , MD;

Zachary M. Gertz , MD;

Daniel M. Kolansky , MD;

Ruchira Glaser , MD, MSCE;

Robert L. Wilensky , MD;

Mark Weiner , MD;

ABSTRACT: Background. Previous investigation has suggested that early discharge after percutaneous coronary intervention (PCI) is feasible and safe, but these studies have utilized largely radial approaches or been conducted in non-U.S....

ABSTRACT: Background. Previous...

09/01/2009

Journal of Invasive Cardiology

Original Contribution

Intermediate-Term Outcomes for Patients With Submassive Pulmonary Embolism Treated With Catheter-Directed Thrombolysis

12/01/2021

William H. Matthai , MD;

Matthew Herzig ;

Sameer Khandhar , MD;

Harold Palevsky , MD;

Jason Fritz , MD;

Mili Mehta , MD;

Matthew Herzig et al aimed to assess the intermediate-term outcomes for patients receiving catheter-directed thrombolysis for submassive pulmonary embolism.

Matthew Herzig et al aimed to...

12/01/2021

Journal of Invasive Cardiology